Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) reported Q3 CY2025 results topping the market’s revenue expectations , with sales up 53.6% year on year to $227.8 million. The ...

Elon Musk’s latest obsession and the project he is super focused on is reportedly Ani, an artificial intelligence girlfriend created by his AI company xAI. According to the Wall Street Journal (WSJ), ...

Good morning, everyone, and welcome to today's ANI Pharmaceuticals Third Quarter 2025 Earnings Results Call. Please note, this call is being recorded. [Operator Instructions] It is now my pleasure to ...

ANI Pharmaceuticals Inc. (ANIP) reported stronger-than-expected earnings for the third quarter of 2025, with earnings per share (EPS) reaching $2.04, surpassing the forecast of $1.76. The company’s ...

ANI Pharmaceuticals recently raised its full-year 2025 earnings guidance, now expecting net revenue of US$854 million to US$873 million, up from the previous forecast of US$818 million to US$843 ...

Elon Musk ordered his staff to hand over biometric data to help train his highly sexualized chatbot while the tech titan worked around the clock to win an AI arms race. The world's richest man threw ...

Simply sign up to the Climate change myFT Digest -- delivered directly to your inbox. The gradual retreat from ambitious climate action among some politicians and companies, emboldened by climate ...

PRINCETON, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the third quarter ended ...